The FDA grants de novo clearance to HeartFlow's novel system for non-invasive measurement of fractional flow reserve, which CEO Dr. John Stevens calls "the gold standard" for diagnosing and treating coronary disease.
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
Westby G. Fisher, MD, FACC is a board certified internist, cardiologist, and cardiac electrophysiologist practicing at NorthShore University HealthSystem in Evanston, IL, USA and is a Clinical Associate Professor of Medicine at University of Chicago's Pritzker School of Medicine.
It was like magic, a vote was held in the House of Representatives on the Medicare "Doc Fix" and moments later, my inbox was filled with press releases from the American College of Cardiology and the AMA. A few seconds later, a somewhat more tempered press release from AARP arrived, urging more revisions to the bill as it passed to the Senate for approval.
The U.S. Senate delays a vote on the so-called 'doc fix' bill to change the way Medicare pays doctors, which passed the House earlier this week.
(Reuters) — The U.S. Senate will wait more than 2 weeks before acting on a bill to permanently fix the flawed formula for reimbursing Medicare physicians, after an April 1 deadline to start a 21% cut in payment rates.